Journal
HEPATOLOGY
Volume 73, Issue 3, Pages 1028-1044Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.31391
Keywords
-
Categories
Funding
- NIHR Cambridge Biomedical Research Centre
- MRC [MR/P01836X/1, MC_UU_00014/5, MR/P011705/2, MR/R023026/1, MR/K001949/1] Funding Source: UKRI
Ask authors/readers for more resources
Our study demonstrates that specific lipid metabolic pathways are coherently altered when hepatocytes switch to proliferation, providing potential targets for therapeutic strategies and prognostic biomarkers of HCC. By integrating metabolomics, lipidomics, and transcriptomics, we have linked changes in the lipidome of proliferating hepatocytes to altered metabolic pathways including lipogenesis and generation of phosphatidylcholine. Additionally, we confirmed this altered lipid signature in human HCC and found a positive correlation of monounsaturated phosphatidylcholine with hallmarks of cell proliferation and hepatic carcinogenesis.
Background and Aims Hepatocytes undergo profound metabolic rewiring when primed to proliferate during compensatory regeneration and in hepatocellular carcinoma (HCC). However, the metabolic control of these processes is not fully understood. In order to capture the metabolic signature of proliferating hepatocytes, we applied state-of-the-art systems biology approaches to models of liver regeneration, pharmacologically and genetically activated cell proliferation, and HCC. Approach and Results Integrating metabolomics, lipidomics, and transcriptomics, we link changes in the lipidome of proliferating hepatocytes to altered metabolic pathways including lipogenesis, fatty acid desaturation, and generation of phosphatidylcholine (PC). We confirm this altered lipid signature in human HCC and show a positive correlation of monounsaturated PC with hallmarks of cell proliferation and hepatic carcinogenesis. Conclusions Overall, we demonstrate that specific lipid metabolic pathways are coherently altered when hepatocytes switch to proliferation. These represent a source of targets for the development of therapeutic strategies and prognostic biomarkers of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available